ProcellaRX has announced the addition of Martin Heitmann as a strategic partner in its Ascend Ecosystem, enhancing its focus on AI governance and decision quality in GxP-regulated environments.
Heitmann, with over ten years of experience in guiding pharmaceutical and life sciences organizations through digital transformation, will contribute to various programs at ProcellaRX, including Decision Quality Intelligence and Quality TEA training. His expertise lies in embedding AI governance into quality systems early in the process, rather than retrofitting it post-regulatory scrutiny.
Heitmann is well-regarded in the life sciences AI governance community, having authored the GAMP® Guide on AI and serving as Secretary of the GAMP Global Special Interest Group. His consultancy, MH Consulting & Advisory GmbH, focuses on AI readiness assessments and governance implementation, aiming to help organizations innovate responsibly. He emphasizes that effective AI governance requires a robust digital foundation and a clear decision-making framework throughout the AI lifecycle.
In welcoming Heitmann, Dori Gonzalez-Acevedo, who leads the Ascend Ecosystem, highlighted the importance of proactive governance in AI implementation, aligning with Heitmann’s philosophy that sustainable digital transformation is achieved through informed decisions and strong governance practices. This partnership aims to fortify the foundations necessary for responsible innovation in the life sciences sector.